Alessandro Mascioni
Director, Targeting Technology Research Telix Pharmaceuticals
Seminars
Thursday 31st July 2025
Pioneering Precision Theragnostics Through Engineered Antibody Fragments
11:30 am
• Exploring strategies for engineering small biologics for use as radioligand therapy
• Emphasizing how to mitigate off-target uptake of the toxic payload
